Kiniksa Pharmaceuticals, Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Lexington MA United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03980522
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kiniksa | Kiniksa Pharmaceuticals, Ltd. | Kiniksa Pharmaceuticals (UK), Ltd. | KINIKSA PHARMACEUTICALS (UK), LTD.